GlassScriptPhysician profile
Jaclyn Beth Gurwin
NPI 1194107649
$1,312.15
in general payments reported to CMS, 2019-2025
11 companies · $722 in 2025
The $722 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $128 · 2023: $199 · 2024: $264 · 2025: $722.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,185.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,184.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $421.99 | 2024-2025 | Clareon, Clareon Panoptix Pro, Tryptyr |
| Glaukos Corporation | $326.75 | 2022-2023 | Istent Infinite Trabecular Micro-Bypass System Model Is3 |
| Amgen INC. | $246.14 | 2024-2025 | Tepezza |
| Ani Pharmaceuticals, INC. | $74.09 | 2025 | Purified Cortrophin Gel |
| Dompe US, INC. | $66.71 | 2025 | Oxervate |
| Merz Pharmaceuticals, LLC | $58.87 | 2025 | Xeomin |
| Abbvie INC. | $38.83 | 2025 | |
| Sun Pharmaceutical Industries INC. | $28.00 | 2025 | |
| Rxsight INC | $21.76 | 2025 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Light Adjustable Lens (Lal) |
| Bausch & Lomb Americas INC. | $14.99 | 2025 | Envista Aspire Iol |
| Thea Pharma INC. | $14.02 | 2025 | Iyuzeh |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jaclyn Gurwin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.